Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
ERCP	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
female	O
with	O
h/o	O
tia,	O
htn,	O
hyperlipidemia	O
presenting	O
for	O
repeat	O
ERCP	O
for	O
choledocholithiasis.	O
Patient	O
initially	O
presented	O
in	O
___	O
with	O
abd	O
pain	O
after	O
eating	O
a	O
muffin.	O
At	O
___	O
she	O
was	O
found	O
to	O
have	O
elevated	O
lft/leukocytosis	O
and	O
ultrasound	O
showed	O
gallstones	O
and	O
cbd	O
dilation	O
to	O
17mm.	O
She	O
was	O
transferred	O
to	O
___	O
for	O
ERCP.	O
Multiple	O
stones	O
were	O
found	O
in	O
the	O
CBD	O
and	O
a	O
sphincterotomy	O
was	O
performed	O
with	O
stent	O
placement.	O
Her	O
symptoms	O
improved	O
and	O
she	O
was	O
discharged	O
on	O
po	O
cipro	O
with	O
planned	O
f/u	O
for	O
repeat	O
ERCP.	O
She	O
had	O
a	O
cholecystectomy	O
at	O
___	O
in	O
the	O
interrim.	O
She	O
denies	O
having	O
any	O
pain/nausea/vomiting	O
since	O
her	O
hospitalization.	O
During	O
ERCP	O
today,	O
the	O
stent	O
was	O
removed	O
and	O
sphincterotomy	O
was	O
extended.	O
Multiple	O
stones	O
were	O
removed	O
from	O
a	O
dilated	O
cbd(14mm).	O
Currently,	O
she	O
denies	O
any	O
abd	O
pain,	O
nausea	O
and	O
no	O
episodes	O
of	O
emesis.	O
Pertinent	O
ROS	O
noted	O
above.	O
Rest	O
of	O
ROS	O
wnl	O
Past	O
Medical	O
History:	O
Hyperlipidemia	O
TIA,	O
on	O
Plavix	O
HTN	O
"Brain	I-Intracranial_haemorrhage
bleed"	B-Intracranial_haemorrhage
5	O
months	O
ago	O
following	O
a	O
fall	B-Falls
(pt	O
report)	O
spina	O
bifida	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
of	O
"heart	O
problems"	O
at	O
___.	O
Mother	O
deceased	O
at	O
age	O
___,	O
also	O
had	O
heart	O
disease.	O
No	O
h/o	O
gallstones	O
Physical	O
Exam:	O
Admission	O
exam:	O
Vitals:	O
Temp:	O
98.3	O
BP:	O
121/56	O
HR:	O
66	O
O2:	O
100RA	O
Gen:	O
Patient	O
lying	O
comfortably	O
on	O
the	O
exam	O
bed	O
nad	O
a+ox3	B-Delirium
HEENT:	O
mmm	O
oropharynx	O
clear	O
Neck:	O
supple	O
no	O
cervical	O
lad	O
CV:	O
RRR	O
no	O
m/r/g	O
Pulm:	O
CTAB	O
no	O
w/r/r	O
Abd:	O
soft	O
nt	O
nd	O
bs+	O
no	O
hepatosplenomegaly.	O
Lap	O
chole	O
scars	O
healing.	O
Ext:	O
no	O
___	O
edema	O
good	O
pedal	O
pulses	O
skin:	O
bruising	O
on	O
abd	O
consistent	O
with	O
heparin	O
injection,	O
no	O
rashes,	O
ulcers	B-Pressure_injury
neuro:	O
cn	O
___	O
intact.	O
___	O
strength	O
in	O
upper/lower	O
extremities	O
psych:	O
normal	O
affect	O
and	O
mood.	O
answer	O
questions	O
appropriately	O
Pertinent	O
Results:	O
___	O
01:30PM	O
UREA	O
N-23*	O
CREAT-0.9	O
SODIUM-139	O
POTASSIUM-4.3	O
CHLORIDE-103	O
TOTAL	O
CO2-24	O
ANION	O
GAP-16	O
___	O
01:30PM	O
estGFR-Using	O
this	O
___	O
01:30PM	O
ALT(SGPT)-11	O
AST(SGOT)-15	O
ALK	O
PHOS-91	O
AMYLASE-38	O
TOT	O
BILI-0.8	O
DIR	O
BILI-0.2	O
INDIR	O
BIL-0.6	O
___	O
01:30PM	O
LIPASE-19	O
___	O
01:30PM	O
WBC-8.0	O
RBC-4.08*	O
HGB-13.4	O
HCT-38.1	O
MCV-93	O
MCH-32.7*	O
MCHC-35.1*	O
RDW-13.1	O
___	O
01:30PM	O
PLT	O
COUNT-310#	O
___	O
01:30PM	O
___	O
PTT-24.6	O
___	O
ERCP	O
report:	O
___:	O
Procedures:	O
A	O
plastic	O
stent	O
was	O
removed.	O
A	O
sphincterotomy	O
was	O
performed	O
in	O
the	O
12	O
o'clock	O
position	O
using	O
a	O
sphincterotome	O
over	O
an	O
existing	O
guidewire.	O
A	O
12mm	O
CRE	O
balloon	O
was	O
introduced	O
for	O
sphincteroplasty	O
and	O
the	O
diameter	O
was	O
progressively	O
increased	O
to	O
13.5	O
mm	O
successfully.	O
Many	O
stones	O
ranging	O
in	O
size	O
from	O
5	O
mm	O
to	O
13	O
mm	O
were	O
extracted	O
successfully	O
using	O
a	O
balloon	O
catheter.	O
Lithotripsy	O
with	O
a	O
mechanical	O
lithotriptor	O
was	O
performed.	O
Impression:	O
Stent	O
in	O
the	O
major	O
papilla	O
(stent	O
removal)	O
Previous	O
sphincterotomy	O
in	O
the	O
major	O
papilla	O
Successful	O
cannulation	O
of	O
the	O
bile	O
duct	O
(cannulation)	O
Multiple	O
bile	O
duct	O
stones	O
with	O
severe	O
biliary	O
dilation	O
up	O
to	O
14	O
mm.	O
A	O
sphincterotomy	O
was	O
performed	O
in	O
the	O
12	O
o'clock	O
position.	O
A	O
12mm	O
CRE	O
balloon	O
was	O
introduced	O
for	O
sphincteroplasty	O
and	O
the	O
diameter	O
was	O
progressively	O
increased	O
to	O
13.5	O
mm	O
successfully.	O
Many	O
stones	O
ranging	O
in	O
size	O
from	O
5	O
mm	O
to	O
13	O
mm	O
were	O
extracted	O
successfully	O
using	O
a	O
balloon	O
catheter.	O
Lithotripsy	O
with	O
an	O
mechanical	O
lithotriptor	O
was	O
performed.	O
(stent	O
removal,	O
sphincterotomy,	O
dilation,	O
stone	O
extraction,	O
lithotripsy)	O
Otherwise	O
normal	O
ercp	O
to	O
third	O
part	O
of	O
the	O
duodenum	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
female	O
with	O
h/o	O
TIA,	O
htn,	O
dyslipidemia	O
with	O
recent	O
admission	O
for	O
cholangitis	O
requiring	O
sphincterotomy/stent	O
placement,	O
returning	O
for	O
repeat	O
ERCP.	O
On	O
admission	O
the	O
stent	O
was	O
removed	O
and	O
sphincterotomy	O
was	O
extended	O
and	O
multiple	O
stones	O
were	O
removed.	O
She	O
tolerated	O
the	O
procedure	O
well	O
with	O
no	O
current	O
abd	O
pain,	O
nausea	O
or	O
emesis.	O
.	O
Choledocholithiasis:	O
Was	O
initially	O
NPO	O
and	O
on	O
unasyn.	O
Diet	O
was	O
advanced	O
in	O
the	O
morning.	O
The	O
patient	O
tolerated	O
a	O
normal	O
diet.	O
She	O
was	O
discharged	O
on	O
7	O
days	O
of	O
augmentin.	O
.	O
TIA:	O
Lipitor	O
was	O
continued.	O
Patient	O
was	O
instructed	O
to	O
hold	O
plavix	O
for	O
five	O
days.	O
.	O
Medications	O
on	O
Admission:	O
1.	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
atenolol	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
losartan	O
50	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
meclizine	O
12.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q12H	O
(every	O
12	O
hours)	O
as	O
needed	O
for	O
dizzy.	O
5.	O
cholecalciferol	O
(vitamin	O
D3)	O
1,000	O
unit	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
6.	O
oxybutynin	O
chloride	O
10	O
mg	O
Tablet	O
Extended	O
Rel	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Extended	O
Rel	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
7.	O
Plavix	O
75mg	O
Plavix	O
is	O
on	O
hold.	O
8.	O
Lipitor	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
9.	O
Fish	O
Oil	O
___	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
PO	O
once	O
a	O
day.	O
10.	O
Colace	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
twice	O
a	O
day	O
as	O
needed	O
for	O
constipation.	B-Constipation
11.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
at	O
bedtime	O
as	O
needed	O
for	O
constipation.	B-Constipation
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
choledocholelithiasis	O
cholelithiasis	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
for	O
a	O
repeat	O
ERCP.	O
You	O
had	O
a	O
stent	O
removed	O
and	O
multiple	O
gall	O
stones	O
were	O
removed.	O
You	O
tolerated	O
the	O
procedure	O
well	O
with	O
no	O
current	O
abdominal	O
pain,	O
nausea	O
or	O
vomiting.	O
You	O
tolerated	O
a	O
normal	O
diet	O
on	O
discharge.	O
All	O
of	O
your	O
medications	O
remain	O
the	O
same.	O
Please	O
continue	O
to	O
take	O
your	O
medications	O
as	O
directed.	O
After	O
this	O
procedure	O
(ERCP)	O
you	O
should	O
not	O
take	O
your	O
plavix	O
for	O
5	O
days.	O
You	O
will	O
take	O
an	O
antibiotic	O
called	O
augmentin	O
for	O
total	O
of	O
7	O
days.	O
Please	O
do	O
not	O
take	O
aspirin,	O
ibuprofen	O
or	O
plavix	O
for	O
five	O
days.	O
Followup	O
Instructions:	O
___	O

